Foot and ankle medical device developer Treace Medical raised $5.9 million in a new round of equity financing, according to an SEC filing posted this week.
Treace Medical is a medical device developer specializing in foot and ankle devices. The company produces the Lapiplasty System, a set of devices designed for a procedure to correct triplanar deformities.
A total of 38 unnamed investors joined in the round, with the 1st date of sale recorded on the May 1, according to the SEC filing.
The Ponte Vedra Beach, Fla.-based company has not yet stated how it plans to spend funds raised in the round.